Nani Morgan1, Michael R Irwin2, Mei Chung3, Chenchen Wang1. 1. Center for Integrative Medicine, Division of Rheumatology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States of America. 2. Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience, University of California Los Angeles, Los Angeles, California, United States of America. 3. Nutrition/Infection Unit, Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Abstract
IMPORTANCE: Psychological and health-restorative benefits of mind-body therapies have been investigated, but their impact on the immune system remain less defined. OBJECTIVE: To conduct the first comprehensive review of available controlled trial evidence to evaluate the effects of mind-body therapies on the immune system, focusing on markers of inflammation and anti-viral related immune responses. METHODS: Data sources included MEDLINE, CINAHL, SPORTDiscus, and PsycINFO through September 1, 2013. Randomized controlled trials published in English evaluating at least four weeks of Tai Chi, Qi Gong, meditation, or Yoga that reported immune outcome measures were selected. Studies were synthesized separately by inflammatory (n = 18), anti-viral related immunity (n = 7), and enumerative (n = 14) outcomes measures. We performed random-effects meta-analyses using standardized mean difference when appropriate. RESULTS: Thirty-four studies published in 39 articles (total 2, 219 participants) met inclusion criteria. For inflammatory measures, after 7 to 16 weeks of mind-body intervention, there was a moderate effect on reduction of C-reactive protein (effect size [ES], 0.58; 95% confidence interval [CI], 0.04 to 1.12), a small but not statistically significant reduction of interleukin-6 (ES, 0.35; 95% CI, -0.04 to 0.75), and negligible effect on tumor necrosis factor-α (ES, 0.21; 95% CI, -0.15 to 0.58). For anti-viral related immune and enumerative measures, there were negligible effects on CD4 counts (ES, 0.15; 95% CI, -0.04 to 0.34) and natural killer cell counts (ES, 0.12, 95% CI -0.21 to 0.45). Some evidence indicated mind-body therapies increase immune responses to vaccination. CONCLUSIONS: Mind-body therapies reduce markers of inflammation and influence virus-specific immune responses to vaccination despite minimal evidence suggesting effects on resting anti-viral or enumerative measures. These immunomodulatory effects, albeit incomplete, warrant further methodologically rigorous studies to determine the clinical implications of these findings for inflammatory and infectious disease outcomes.
IMPORTANCE: Psychological and health-restorative benefits of mind-body therapies have been investigated, but their impact on the immune system remain less defined. OBJECTIVE: To conduct the first comprehensive review of available controlled trial evidence to evaluate the effects of mind-body therapies on the immune system, focusing on markers of inflammation and anti-viral related immune responses. METHODS: Data sources included MEDLINE, CINAHL, SPORTDiscus, and PsycINFO through September 1, 2013. Randomized controlled trials published in English evaluating at least four weeks of Tai Chi, Qi Gong, meditation, or Yoga that reported immune outcome measures were selected. Studies were synthesized separately by inflammatory (n = 18), anti-viral related immunity (n = 7), and enumerative (n = 14) outcomes measures. We performed random-effects meta-analyses using standardized mean difference when appropriate. RESULTS: Thirty-four studies published in 39 articles (total 2, 219 participants) met inclusion criteria. For inflammatory measures, after 7 to 16 weeks of mind-body intervention, there was a moderate effect on reduction of C-reactive protein (effect size [ES], 0.58; 95% confidence interval [CI], 0.04 to 1.12), a small but not statistically significant reduction of interleukin-6 (ES, 0.35; 95% CI, -0.04 to 0.75), and negligible effect on tumor necrosis factor-α (ES, 0.21; 95% CI, -0.15 to 0.58). For anti-viral related immune and enumerative measures, there were negligible effects on CD4 counts (ES, 0.15; 95% CI, -0.04 to 0.34) and natural killer cell counts (ES, 0.12, 95% CI -0.21 to 0.45). Some evidence indicated mind-body therapies increase immune responses to vaccination. CONCLUSIONS: Mind-body therapies reduce markers of inflammation and influence virus-specific immune responses to vaccination despite minimal evidence suggesting effects on resting anti-viral or enumerative measures. These immunomodulatory effects, albeit incomplete, warrant further methodologically rigorous studies to determine the clinical implications of these findings for inflammatory and infectious disease outcomes.
Authors: Barry S Oken; Irina Fonareva; Mitchell Haas; Helane Wahbeh; James B Lane; Daniel Zajdel; Alexandra Amen Journal: J Altern Complement Med Date: 2010-10-07 Impact factor: 2.579
Authors: Nancy L McCain; D Patricia Gray; R K Elswick; Jolynne W Robins; Inez Tuck; Jeanne M Walter; Sarah M Rausch; Jessica McKinney Ketchum Journal: J Consult Clin Psychol Date: 2008-06
Authors: Helen Lavretsky; Lily L Alstein; Richard E Olmstead; Linda M Ercoli; Marquertie Riparetti-Brown; Natalie St Cyr; Michael R Irwin Journal: Am J Geriatr Psychiatry Date: 2011-10 Impact factor: 4.105
Authors: Michael R Irwin; Richard Olmstead; Elizabeth C Breen; Tuff Witarama; Carmen Carrillo; Nina Sadeghi; Jesusa M G Arevalo; Jeffrey Ma; Perry Nicassio; Patricia A Ganz; Julienne E Bower; Steve Cole Journal: J Natl Cancer Inst Monogr Date: 2014-11
Authors: Chenchen Wang; Christopher H Schmid; Ramel Rones; Robert Kalish; Janeth Yinh; Don L Goldenberg; Yoojin Lee; Timothy McAlindon Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Michelle C Janelsins; Paul G Davis; Laurie Wideman; Jeffrey A Katula; Lisa K Sprod; Luke J Peppone; Oxana G Palesh; Charles E Heckler; Jacqueline P Williams; Gary R Morrow; Karen M Mustian Journal: Clin Breast Cancer Date: 2011-04-20 Impact factor: 3.225
Authors: Nicole D Powell; Erica K Sloan; Michael T Bailey; Jesusa M G Arevalo; Gregory E Miller; Edith Chen; Michael S Kobor; Brenda F Reader; John F Sheridan; Steven W Cole Journal: Proc Natl Acad Sci U S A Date: 2013-09-23 Impact factor: 11.205
Authors: Francisca M Vera; Juan M Manzaneque; Francisco M Rodríguez; Rebecca Bendayan; Nieves Fernández; Antonio Alonso Journal: Int J Behav Med Date: 2016-04
Authors: Dilorom M Djalilova; Paula S Schulz; Ann M Berger; Adam J Case; Kevin A Kupzyk; Alyson C Ross Journal: Biol Res Nurs Date: 2018-12-20 Impact factor: 2.522
Authors: Melissa A Rosenkranz; Antoine Lutz; David M Perlman; David R W Bachhuber; Brianna S Schuyler; Donal G MacCoon; Richard J Davidson Journal: Psychoneuroendocrinology Date: 2016-02-20 Impact factor: 4.905
Authors: Chenchen Wang; Christopher H Schmid; Maura D Iversen; William F Harvey; Roger A Fielding; Jeffrey B Driban; Lori Lyn Price; John B Wong; Kieran F Reid; Ramel Rones; Timothy McAlindon Journal: Ann Intern Med Date: 2016-05-17 Impact factor: 25.391